Literature DB >> 10757584

Assessment of postoperative nausea using a visual analogue scale.

J G Boogaerts1, E Vanacker, L Seidel, A Albert, F M Bardiau.   

Abstract

BACKGROUND: Assessment of postoperative nausea intensity is difficult because nausea is a subjective and unpleasant sensation. We propose using the Visual Analogue Scale (VAS) device to increase the efficiency and precision in the assessment of nausea. We carried out a pilot study on postoperative patients suffering from nausea to measure the degree of agreement between the VAS scores and those given on a 4-point verbal descriptive scale (VDS).
METHODS: Postoperative nausea was evaluated by means of a classical VAS (0-10 cm) device and a 4-point VDS (0=no nausea, 1=mild, 2=moderate, 3=severe) in 128 surgical spontaneously complaining patients. Evaluation was repeated 45 min after rescue medication given if nausea was intractable, lasted more than 10 min or at the request of the patient. Ordinal logistic regression was used to measure the association between VAS and VDS and to determine cut-off points on the VAS.
RESULTS: The VAS device was easily understood and used by patients. VAS scores decreased significantly from 5.5+/-2.3 to 1.4+/-1.8 after rescue medication (P=0.002). Application of ordinal logistic regression to pre- and post-medication data combined yielded an agreement of 86% between VAS and VDS and the cut-off points on the VAS were estimated as follows: 0-1 (no nausea), 1+/-4 (mild), 4+/-7 (moderate) and 7+/-10 (severe).
CONCLUSION: The VAS method proved to be useful for assessing quantitative nausea intensity and for testing the efficacy of rescue medication. It was found that a cut-off value of 4 on the VAS may be considered as a critical threshold triggering anaesthesiologists or nurses to administer rescue medication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757584     DOI: 10.1034/j.1399-6576.2000.440420.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  24 in total

1.  Does ramosetron reduce postoperative emesis and pain after TKA?

Authors:  In Jun Koh; Chong Bum Chang; Young-Tae Jeon; Jung-Hee Ryu; Tae Kyun Kim
Journal:  Clin Orthop Relat Res       Date:  2011-12-13       Impact factor: 4.176

2.  Preoperative education in cholecystectomy in the context of a multimodal protocol of perioperative care: a randomized, controlled trial.

Authors:  José E de Aguilar-Nascimento; Fernando S Leal; Daniela C S Dantas; Nadia T Anabuki; Amanda M C de Souza; Verônica P Silva E Lima; Guilherme H Tanajura; Mariana Canevari
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

3.  Comparison of the effects of intra-articular sole ropivacaine and combined ketorolac and ropivacaine for pain control after knee arthroscopy surgery.

Authors:  Faranak Rokhtabnak; Mahmood Reza Ale Bouyeh; Alireza Seyed Siamdust; Mehdi Masoomshahi; Marjan Aghajani
Journal:  Br J Pain       Date:  2015-08

4.  Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents.

Authors:  Maria Metaxari; Alexandra Papaioannou; Anastasios Petrou; Aikaterini Chatzimichali; Elena Pharmakalidou; Helen Askitopoulou
Journal:  J Anesth       Date:  2011-03-23       Impact factor: 2.078

5.  Copeptin as a marker for arginine-vasopressin/antidiuretic hormone secretion in the diagnosis of paraneoplastic syndrome of inappropriate ADH secretion.

Authors:  A Wuttke; K C Dixit; G Szinnai; S C Werth; U Haagen; M Christ-Crain; N Morgenthaler; G Brabant
Journal:  Endocrine       Date:  2013-03-12       Impact factor: 3.633

6.  Mediators of a brief hypnosis intervention to control side effects in breast surgery patients: response expectancies and emotional distress.

Authors:  Guy H Montgomery; Michael N Hallquist; Julie B Schnur; Daniel David; Jeffrey H Silverstein; Dana H Bovbjerg
Journal:  J Consult Clin Psychol       Date:  2010-02

7.  One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient.

Authors:  Anna Enblom; Beata Bergius Axelsson; Gunnar Steineck; Mats Hammar; Sussanne Börjeson
Journal:  Support Care Cancer       Date:  2008-06-05       Impact factor: 3.603

8.  Postoperative Nausea and Vomiting: Palonosetron with Dexamethasone vs. Ondansetron with Dexamethasone in Laparoscopic Hysterectomies.

Authors:  Anish N G Sharma; Paniye Shankaranarayana
Journal:  Oman Med J       Date:  2015-07

9.  Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial.

Authors:  Zhihuang Hu; Ying Cheng; Hongyu Zhang; Caicun Zhou; Baohui Han; Yiping Zhang; Cheng Huang; Jianhua Chang; Xiangqun Song; Jun Liang; Houjie Liang; Chunxue Bai; Shiying Yu; Jia Chen; Jie Wang; Hongming Pan; Denesh K Chitkara; Darcy A Hille; Li Zhang
Journal:  Support Care Cancer       Date:  2013-11-26       Impact factor: 3.603

10.  Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study.

Authors:  Sung-Hoon Kim; Jeong-Yeon Hong; Won Oak Kim; Hae Keum Kil; Myong-Hwan Karm; Jai-Hyun Hwang
Journal:  Korean J Anesthesiol       Date:  2013-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.